Amazon Slapped “Hypoallergenic” On a Body Wash That Contains Known Skin Allergens

EvilCorporations.com • Case No. 1:26-cv-1062, S.D.N.Y., Filed Feb. 6, 2026 • 17 min read

Amazon built a trillion-dollar empire partly on the promise that its own-brand products are cheaper, no-frills alternatives to name brands. The Amazon Basics line is supposed to be trustworthy precisely because Amazon makes it. So when someone with psoriasis sees the word “Hypoallergenic” stamped in bold on an Amazon Basics body wash, they reasonably trust it. That trust, according to a federal lawsuit filed February 6, 2026, is exactly what Amazon exploited.

The product is the Amazon Basics Hypoallergenic Body Wash for Sensitive Skin. The front label promises gentle cleansing, dermatologist-tested safety, parabens-free formulation, and hypoallergenic status. The back label, in fine print, lists “FRAGRANCE” as an ingredient. Fragrances are one of the most common causes of allergic skin reactions in the United States. There is no legal definition requiring a product to prove anything before it can use the word “hypoallergenic.” Amazon knew this. And it used that gap to charge a premium for a product that is, by the complaint’s evidence, identical to its non-hypoallergenic alternative.

What This Actually Feels Like When You Have Psoriasis

SeQuoia King lives in the Bronx. She has psoriasis, a chronic autoimmune skin condition that causes the skin to produce cells far faster than normal, resulting in scaly, inflamed patches that can crack, bleed, and itch without mercy. People with psoriasis spend significant time and money managing triggers. Diet. Stress. Weather. And especially, the products they put directly onto their skin every single day.

Standing in front of a product labeled “Hypoallergenic” and “For Sensitive Skin,” she made a reasonable calculation. She read the label. It said dermatologist tested. It said gentle cleaning. It said hypoallergenic. It was an Amazon product. She trusted it. She bought it. She bought it more than once.

Here is what the complaint does not dwell on, but deserves to be said plainly: she was washing her already inflamed, already fragile skin with a product that contained fragrance chemicals. Every time she showered, she may have been introducing one or more of the over 3,000 chemicals that can hide under the single word “FRAGRANCE” directly onto compromised skin, while believing she was protecting herself. The itch that would not go away. The flare she could not explain. The routine she built around a product she trusted. All of it potentially undermined by a label Amazon chose to print and a formula Amazon chose not to change.

She is not alone in this story. She is a named plaintiff representing thousands of people in New York who bought this product for the same reason. People managing eczema, contact dermatitis, fragrance allergies, and other skin conditions that make the difference between a “regular” body wash and a “hypoallergenic” one genuinely meaningful. These are not luxury shoppers trying to buy premium products for vanity. These are people with medical conditions doing the basic, reasonable thing: reading the label and trusting what it says.

The complaint points out something that should anger anyone who has ever stood in a pharmacy or scrolled through Amazon trying to find something safe: Amazon sells a standard moisturizing body wash with an identical ingredient list at what is effectively a lower implied promise. The “hypoallergenic” version commands more trust, and presumably a higher price, for a product that is chemically the same thing. Fragrance and all. The only thing Amazon changed was the words on the label.

The FDA tried to fix this in the 1970s. It proposed rules that would require products to actually prove reduced allergic reactions before using the word “hypoallergenic.” Big manufacturers fought back. They said the testing would cost too much. The FDA backed down. Fifty-plus years later, “hypoallergenic” still means nothing legally, and companies like Amazon still use it to sell products to people whose skin cannot afford the deception.

Verbatim: What the Court Filing Actually Says

These are direct quotes from Case No. 1:26-cv-1062, filed February 6, 2026, in the Southern District of New York. Not paraphrased. Not editorialized. This is what lawyers filed in federal court under their names.

“The Product isn’t hypoallergenic. The Product is made with fragrance chemicals and fragrance chemicals are some of the most common causes of skin allergies. As the American Academy of Dermatology has explained, about 2.5 million Americans have fragrance allergies.”
— Complaint ¶4

• This directly contradicts the front label’s central claim. The complaint is asserting, as a legal allegation, that Amazon put the word “hypoallergenic” on a product that contains a class of ingredients responsible for allergic reactions in 2.5 million Americans.
• The phrase “made with fragrance chemicals” is not ambiguous. The “FRAGRANCE” listing appears on the product’s own ingredient label, making this allegation based on Amazon’s own disclosure on the back panel.

“By claiming that the Product is a simple, clean, hypoallergenic product, Defendants take advantage of this market desire while selling a Product loaded with allergen-causing fragrance chemicals.”
— Complaint ¶5

• The legal term “take advantage” frames this as intentional exploitation, not accident. Amazon is a sophisticated company with full control over its own-brand labeling and formulation. The complaint argues this was a deliberate business decision.
• “Loaded with” is the plaintiff’s characterization, but it rests on the fact that “FRAGRANCE” can represent any combination of over 3,000 individual chemicals, with quantity and composition entirely undisclosed.

“Both list the final ingredient as ‘FRAGRANCE.’ It is entirely unclear what makes Defendants’ Hypoallergenic Product, for sensitive skin, different from any others. And, it does not appear that the Hypoallergenic Product removes known irritants that supposedly warrants a label different from the non-hypoallergenic products.”
— Complaint ¶29

• This is the single most damaging factual allegation in the complaint. The complaint compares the actual ingredient lists of both products side-by-side and finds them to be identical. If true, there is no scientific basis for a different label.
• The phrase “entirely unclear” is doing legal work here. It signals that the defendants will have a very hard time at trial explaining what, exactly, justifies the “hypoallergenic” designation when the formula is the same.

“Defendants were able to sell the Product at a higher price than they otherwise could as a result of the claim that the Product is hypoallergenic.”
— Complaint ¶50

• This establishes economic injury, which is a required element under both GBL §349 and §350. The plaintiff is not just arguing harm to health; she is arguing harm to wallet. She paid a premium for a product whose premium was manufactured by a deceptive label.
• This allegation also opens the door to disgorgement. If Amazon profited from a price premium it earned through deception, the court can order those profits returned to the class.

“Defendants knew, as the entities controlling the labeling, marketing, and production of the Product, the messages they caused to be printed while concurrently affixing the labeling at issue to a Product that contained fragrances as an ingredient—and otherwise had an identical ingredient composition to its non-hypoallergenic products.”
— Complaint ¶32

• The word “knew” elevates this from negligence toward intentional deception. Amazon controls the entire pipeline for this product: the formula, the manufacturing specs, the label design, and the marketing copy. The complaint argues there is no way Amazon did not know what the product contained.
• “Concurrently affixing” is the legal way of saying Amazon printed “hypoallergenic” and added fragrance to the same product at the same time, which is the heart of the fraud claim.

The Scale of Harm Beyond One Lawsuit

The complaint’s factual allegations connect this single product to a documented, national public health pattern involving fragrance sensitivity and skin disease.

• An estimated 2.5 million Americans have fragrance allergies, according to the American Academy of Dermatology. A product marketed as “hypoallergenic” that contains fragrance chemicals is therefore potentially hazardous for a population already identified as vulnerable.
• Approximately 16.5 million adults in the United States suffer from eczema. Ninety percent of them report that their choice of cleanser directly impacts flare frequency. A body wash falsely labeled as safe for sensitive skin can directly worsen this condition for millions of people making daily purchase decisions based on the label.
• Contact dermatitis, one of the documented outcomes of fragrance exposure, presents as rashes, blisters, cracked or leathery skin, persistent itching, and dry skin. It can occur without any visible rash, meaning a person may experience symptoms without being able to identify the cause, particularly if they trust the “hypoallergenic” label and never suspect their body wash.
• Researchers analyzed 187 children’s personal care products bearing labels such as “hypoallergenic,” “dermatologist recommended,” and “paraben free.” Eighty-nine percent contained at least one chemical known to cause a skin rash. Eleven percent contained five or more contact allergens. The Amazon product fits squarely within this documented industry-wide pattern.
• The American Academy of Dermatology recorded a 33% increase in consumer inquiries about fragrance-free and hypoallergenic soaps between 2020 and 2023. That rising demand signals that more people with skin conditions are actively seeking protection. It also signals a larger market for deception, as companies rush to label products “hypoallergenic” to capture those consumers.

The economics of this deception fall hardest on people who cannot afford specialist care and who rely on product labels to make safe purchasing decisions.

• Amazon Basics products are explicitly positioned as budget-friendly alternatives. The people most likely to buy them are those who cannot afford to consult a dermatologist, purchase premium fragrance-free medical-grade brands, or run patch testing. They rely on the label. The label lied.
• The complaint alleges Amazon sold the “hypoallergenic” version at a higher price than it otherwise could have specifically because of the false safety claim. Lower-income consumers who specifically sought the cheaper Amazon Basics option in pursuit of a “safe” product were therefore paying a premium extracted through deception.
• The potential class covers thousands of consumers in New York who purchased this product during the applicable statute of limitations period. Each one may have paid a premium for a product offering no genuine medical benefit over the standard version. For people managing skin conditions on a tight budget, every dollar spent on a product that worsens rather than protects their condition is a compounded harm.
• When symptoms arise, low-income consumers with skin conditions face further economic injury: medical visits, topical treatments, missed work. If a false “hypoallergenic” label is triggering flares in eczema and psoriasis patients, the downstream medical costs are borne by the individual, not by Amazon.
• The hypoallergenic products market is projected to exceed $80 billion by 2030. Amazon’s deceptive label is a play for a share of that massive market at the expense of the vulnerable consumers who are creating it.

What Amazon Stands to Gain Versus What Class Members Are Owed

Who to Pressure, What to Watch, and How to Push Back

This lawsuit is live. Case No. 1:26-cv-1062 is before the Southern District of New York. Here is what you can do with this information right now.

The People Running This

The complaint names both Amazon.com Services LLC and Amazon.com, Inc. as defendants. Plaintiff is represented by attorneys Max S. Roberts, Victoria X. Zhou, and Caroline C. Donovan of Bursor & Fisher, P.A., New York.

Regulatory Watchlist

• FDA (Food and Drug Administration): Has jurisdiction over cosmetic labeling claims including “hypoallergenic.” The FDA’s own website acknowledges the term has no legal definition. Pressure the FDA to establish enforceable standards for hypoallergenic claims on skin-contact products.
• FTC (Federal Trade Commission): Regulates deceptive advertising in commerce. A product advertised as hypoallergenic that contains documented skin allergens may constitute a deceptive trade practice under FTC Act Section 5. The FTC accepts consumer complaints at reportfraud.ftc.gov.
• New York Attorney General: NY GBL §§ 349 and 350, the statutes under which this case is filed, are also enforceable by the NY AG’s office. Consumer complaints about deceptive labeling can be filed directly with the AG’s consumer protection bureau.
• CPSC (Consumer Product Safety Commission): Has oversight over consumer product safety, including products that cause skin reactions. Adverse event reports related to this product can be submitted to SaferProducts.gov.

What You Can Do

• If you bought this product in New York: You may be a member of the class. Contact Bursor & Fisher, P.A. at mroberts@bursor.com to inquire about participation in the class action.
• Leave an honest review: Amazon’s product reviews are one of the few tools consumers have. If you purchased this product and experienced skin reactions while using it, document it and report it on the product page. Flag any listing that uses “hypoallergenic” while containing fragrance chemicals.
• Share this with anyone you know who has eczema, psoriasis, or fragrance sensitivities: The class period covers ongoing purchases. People in your community may still be buying this product today while believing the front label’s claims.
• Demand ingredient transparency: Contact Amazon customer service and the Amazon Basics product team directly and ask them to disclose the specific fragrance chemicals in this product. Every inquiry creates a paper trail.
• Support local and mutual aid networks for people with chronic skin conditions: Organizations supporting eczema and psoriasis patients often run education campaigns around product safety. Connect with the National Eczema Association (nationaleczema.org) and the National Psoriasis Foundation (psoriasis.org) to report this case and support their advocacy work.
• Push for federal legislation: The reason Amazon can legally do this is because the FDA never established a standard. Contact your Congressional representatives and demand they co-sponsor legislation requiring cosmetic companies to substantiate “hypoallergenic” claims before using them in marketing.